Is Staphylococcus epidermidis resistant to vancomycin? An Exploration of Mechanisms and Clinical Impact
•
4 min read
While vancomycin has long been the frontline treatment for multidrug-resistant coagulase-negative staphylococci, the emergence of vancomycin-resistant *Staphylococcus epidermidis* (VRSE) and vancomycin-intermediate *S. epidermidis* (VISE) is a growing concern. This resistance, often driven by sub-populations known as heteroresistance, poses significant challenges for patient outcomes, particularly in healthcare settings.
